Platelet distribution width (PDW) as a significant correlate of COVID-19 infection severity and mortality.
COVID-19
PDW
SARS-CoV-2
platelet
platelet distribution width
systematic review
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
20 Sep 2023
20 Sep 2023
Historique:
received:
14
06
2023
accepted:
01
09
2023
medline:
19
9
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
aheadofprint
Résumé
SARS-CoV-2 infection may cause a wide spectrum of symptoms, from asymptomatic, to mild respiratory symptoms and life-threatening sepsis. Among the clinical laboratory biomarkers analyzed during COVID-19 pandemic, platelet indices have raised great interest, due to the critical involvement of platelets in COVID-19-related thromboinflammation. Through an electronic literature search on MEDLINE, CINAHL, PubMed, EMBASE, Web of Science, and preprint servers we performed and updated a systematic review aimed at providing a detailed analysis of studies addressing the potential clinical utility of platelet distribution width, platelet distribution width (PDW), in laboratory medicine, exploring the possible association between increased PDW levels, disease severity, and mortality in COVID-19. Our systematic review revealed a wide heterogeneity of COVID-19 cohorts examined and a lack of homogenous expression of platelet indices. We found that 75 % of studies reported significantly elevated PDW values in COVID-19 infected cohorts compared to healthy/non-COVID-19 controls, and 40 % of studies reported that patients with severe COVID-19 showed increased PDW values than those with less-than-severe illness. Interestingly, 71.4 % of studies demonstrated significant increased PDW values in non survivors vs. survivors. Overall, these results suggest that platelets are critically involved as major players in the process of immunothrombosis in COVID-19, and platelet reactivity and morphofunctional alterations are mirrored by PDW, as indicator of platelet heterogeneity. Our results confirm that the use of PDW as prognostic biomarkers of COVID-19 sepsis still remains debated due to the limited number of studies to draw a conclusion, but new opportunities to investigate the crucial role of platelets in thrombo-inflammation are warranted.
Identifiants
pubmed: 37725416
pii: cclm-2023-0625
doi: 10.1515/cclm-2023-0625
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
Références
Dobrijević, D, Katanić, J, Todorović, M, Vučković, B. Baseline laboratory parameters for preliminary diagnosis of COVID-19 among children: a cross-sectional study. Sao Paulo Med J 2022;140:691–6. https://doi.org/10.1590/1516-3180.2021.0634.r1.05012022 .
doi: 10.1590/1516-3180.2021.0634.r1.05012022
Bell, TD. COVID-19 in the critically ill patient. Infect Dis Clin North Am 2022;36:365–77. https://doi.org/10.1016/j.idc.2022.02.005 .
doi: 10.1016/j.idc.2022.02.005
Lippi, G, Plebani, M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med 2020;58:1063–9. https://doi.org/10.1515/cclm-2020-0240 .
doi: 10.1515/cclm-2020-0240
Henry, BM, de Oliveira, MHS, Benoit, S, Plebani, M, Lippi, G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–8. https://doi.org/10.1515/cclm-2020-0369 .
doi: 10.1515/cclm-2020-0369
Ahmadi, E, Bagherpour, Z, Zarei, E, Omidkhoda, A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: alterations in count, morphology, and function. Pathol Res Pract 2022;231:153782. https://doi.org/10.1016/j.prp.2022.153782 .
doi: 10.1016/j.prp.2022.153782
Wool, GD, Miller, JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology 2021;88:15–27. https://doi.org/10.1159/000512007 .
doi: 10.1159/000512007
Palladino, M. Complete blood count alterations in COVID-19 patients: a narrative review. Biochem Med 2021;31:030501. https://doi.org/10.11613/bm.2021.030501 .
doi: 10.11613/bm.2021.030501
Comer, SP, Cullivan, S, Szklanna, PB, Weiss, L, Cullen, S, Kelliher, S, et al.. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol 2021;19:e3001109. https://doi.org/10.1371/journal.pbio.3001109 .
doi: 10.1371/journal.pbio.3001109
Yardımcı, AC, Yıldız, S, Ergen, E, Ballı, H, Ergene, E, Guner, YS, et al.. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19. Eur Rev Med Pharmacol Sci 2021;25:6731–40. https://doi.org/10.26355/eurrev_202111_27118 .
doi: 10.26355/eurrev_202111_27118
Wang, Y, Fan, Z, Wang, S, Zhuang, C. The diagnostic value of platelet distribution width in patients with mild COVID-19. J Clin Lab Anal 2021;35:e23703. https://doi.org/10.1002/jcla.23703 .
doi: 10.1002/jcla.23703
Tzur, I, Barchel, D, Izhakian, S, Swarka, M, Garach-Jehoshua, O, Krutkina, E, et al.. Platelet distribution width: a novel prognostic marker in an internal medicine ward. J Community Hosp Intern Med Perspect 2019;9:464–70. https://doi.org/10.1080/20009666.2019.1688095 .
doi: 10.1080/20009666.2019.1688095
Güçlü, E, Kocayiğit, H, Okan, HD, Erkorkmaz, U, Yürümez, Y, Yaylacı, S, et al.. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras 2020;66:1122–7. https://doi.org/10.1590/1806-9282.66.8.1122 .
doi: 10.1590/1806-9282.66.8.1122
Vagdatli, E, Gounari, E, Lazaridou, E, Katsibourlia, E, Tsikopoulou, F, Labrianou, I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010;14:28–32.
Gao, Y, Li, Y, Yu, X, Guo, S, Ji, X, Sun, T, et al.. The impact of various platelet indices as prognostic markers of septic shock. PLoS One 2014;9:e103761. https://doi.org/10.1371/journal.pone.0103761 .
doi: 10.1371/journal.pone.0103761
Kamisli, O, Kamisli, S, Kablan, Y, Gonullu, S, Ozcan, C. The prognostic value of an increased mean platelet volume and platelet distribution width in the early phase of cerebral venous sinus thrombosis. Clin Appl Thromb Hemost 2013;19:29–32. https://doi.org/10.1177/1076029612453196 .
doi: 10.1177/1076029612453196
Sevuk, U, Bahadir, MV, Altindag, R, Baysal, E, Yaylak, B, Ay, N, et al.. Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis. Therapeut Clin Risk Manag 2015;11:1243–9. https://doi.org/10.2147/tcrm.s89355 .
doi: 10.2147/tcrm.s89355
Ulucan, Ş, Keser, A, Kaya, Z, Katlandur, H, Özdil, H, Bilgi, M, et al.. Association between PDW and long term major adverse cardiac events in patients with acute coronary syndrome. Heart Lung Circ 2016;25:29–34. https://doi.org/10.1016/j.hlc.2015.05.017 .
doi: 10.1016/j.hlc.2015.05.017
Al-Buthabhak, K, Nafakhi, H, Shukur, MH, Nafakhi, A, Alareedh, M, Shaghee, F. Blood indices, in-hospital outcome and short-term prognosis in patients with COVID-19 pneumonia. Monaldi Arch Chest Dis 2021. https://doi.org/10.4081/monaldi.2021.1782 .
doi: 10.4081/monaldi.2021.1782
Alnor, A, Sandberg, MB, Toftanes, BE, Vinholt, PJ. Platelet parameters and leukocyte morphology is altered in COVID-19 patients compared to non-COVID-19 patients with similar symptomatology. Scand J Clin Lab Invest 2021;81:213–7. https://doi.org/10.1080/00365513.2021.1894601 .
doi: 10.1080/00365513.2021.1894601
Aydınyılmaz, F, Aksakal, E, Pamukcu, HE, Aydemir, S, Doğan, R, Saraç, İ, et al.. Significance of MPV, RDW and PDW with the severity and mortality of COVID-19 and effects of acetylsalicylic acid use. Clin Appl Thromb Hemost 2021;27:10760296211048808. https://doi.org/10.1177/10760296211048808 .
doi: 10.1177/10760296211048808
Nori, W, Hameed, BH, Thamir, AR, Fadhil, A. COVID-19 in pregnancy: implication on platelets and blood indices. Rev Bras Ginecol Obstet 2021;43:595–9. https://doi.org/10.1055/s-0041-1733912 .
doi: 10.1055/s-0041-1733912
Shankaralingappa, A, Tummidi, S, Arun Babu, T. Diagnostic value of platelet indices in COVID 19 infection: a case-control study from a single tertiary care center. Egypt J Intern Med 2022;34:35. https://doi.org/10.1186/s43162-022-00123-x .
doi: 10.1186/s43162-022-00123-x
Yovchevska, IP, Trenovski, AB, Atanasova, MH, Georgiev, MN, Tafradjiiska-Hadjiolova, RK, Lazarov, SD, et al.. Platelet distribution width and increased D-dimer at admission predicts subsequent development of ARDS in COVID-19 patients. Pathophysiology 2022;29:233–42. https://doi.org/10.3390/pathophysiology29020019 .
doi: 10.3390/pathophysiology29020019
Asrie, F, Tekle, E, Gelaw, Y, Dagnew, M, Gelaw, A, Negash, M, et al.. Baseline thrombocytopenia and disease severity among COVID-19 patients, tibebe ghion specialized hospital COVID-19 treatment center, northwest Ethiopia. J Blood Med 2022;13:315–25. https://doi.org/10.2147/jbm.s366478 .
doi: 10.2147/jbm.s366478
Bommenahalli Gowda, S, Gosavi, S, Ananda Rao, A, Shastry, S, Raj, SC, Menon, S, et al.. Prognosis of COVID-19: red cell distribution width, platelet distribution width, and C-reactive protein. Cureus 2021;13:e13078. https://doi.org/10.7759/cureus.13078 .
doi: 10.7759/cureus.13078
Suarez Castillejo, C, Toledo-Pons, N, Calvo, N, Ramon-Clar, L, Martínez, J, Hermoso de Mendoza, S, et al.. A prospective study evaluating cumulative incidence and a specific prediction rule in pulmonary embolism in COVID-19. Front Med 2022;9:936816. https://doi.org/10.3389/fmed.2022.936816 .
doi: 10.3389/fmed.2022.936816
Çelikkol, A, Güzel, E, Doğan, M, Erdal, B, Yilmaz, A. C-reactive protein-to-albumin ratio as a prognostic inflammatory marker in COVID-19. J Lab Physicians 2022;14:74–83. https://doi.org/10.1055/s-0041-1741439 .
doi: 10.1055/s-0041-1741439
Covali, R, Socolov, D, Socolov, R, Pavaleanu, I, Carauleanu, A, Akad, M, et al.. Complete blood count peculiarities in pregnant SARS-CoV-2-infected patients at term: a cohort study. Diagnostics 2021;12:80. https://doi.org/10.3390/diagnostics12010080 .
doi: 10.3390/diagnostics12010080
Hajian, S, Sarbazi-Golezari, A, Karbasi, M, Oveisi, S, Ahmadi, MH, Sotoudeh, M, et al.. Evaluation of the relation between disease severity with platelet distribution width, platelet large cell ratio, mean platelet volume and red cell distribution width in severe and critically ill hospitalized patients with coronavirus disease 2019. J Parathyr Dis 2022;10:e10156. https://doi.org/10.34172/jpd.2022.10156 .
doi: 10.34172/jpd.2022.10156
Khalid, A, Suliman, AM, Abdallah, EI, Abakar, MAA, Elbasheir, MM, Muddathir, AM, et al.. Influence of COVID-19 on lymphocyte and platelet parameters among patients admitted to intensive care unit and emergency. Eur Rev Med Pharmacol Sci 2022;26:2579–85. https://doi.org/10.26355/eurrev_202204_28495 .
doi: 10.26355/eurrev_202204_28495
László, I, Berhés, M, Tisza, K, Miltényi, Z, Balázsfalvi, N, Vaskó, A, et al.. The prognostic value of laboratory parameters referring to hemopoietic stress in patients with COVID-19—a single center experience. Signa Vitae 2023;19:36–43.
Ouyang, SM, Zhu, HQ, Xie, YN, Zou, ZS, Zuo, HM, Rao, YW, et al.. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19. BMC Infect Dis 2020;20:952. https://doi.org/10.1186/s12879-020-05678-0 .
doi: 10.1186/s12879-020-05678-0
Ozcelik, N, Ozyurt, S, Yilmaz Kara, B, Gumus, A, Sahin, U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol 2021;93:2221–6. https://doi.org/10.1002/jmv.26645 .
doi: 10.1002/jmv.26645
Pujani, M, Raychaudhuri, S, Verma, N, Kaur, H, Agarwal, S, Singh, M, et al.. Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective. Am J Blood Res 2021;11:180–90.
Ravindra, R, Ramamurthy, P, Aslam, SS, Kulkarni, A, Suhail, K, Ramamurthy, PS. Platelet indices and platelet to lymphocyte ratio (PLR) as markers for predicting COVID-19 infection severity. Cureus 2022;14:e28206. https://doi.org/10.7759/cureus.28206 .
doi: 10.7759/cureus.28206
Suliman, BA. Dynamics of COVID-19 lockdown on blood indices and its impact on individuals’ immunological health status: a cohort study in madinah, Saudi Arabia. J Blood Med 2021;12:395–402. https://doi.org/10.2147/jbm.s312177 .
doi: 10.2147/jbm.s312177
Ye, J, Hua, M, Zhu, F. Machine learning algorithms are superior to conventional regression models in predicting risk stratification of COVID-19 patients. Risk Manag Healthc Policy 2021;14:3159–66. https://doi.org/10.2147/rmhp.s318265 .
doi: 10.2147/rmhp.s318265
Zhong, Q, Peng, J. Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID-19. J Clin Lab Anal 2021;35:e23607. https://doi.org/10.1002/jcla.23607 .
doi: 10.1002/jcla.23607
Giglio, RV, Ligi, D, Della Franca, C, Lo Sasso, B, Rivas, JZ, Agnello, L, et al.. Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood. Clin Chem Lab Med 2023. https://doi.org/10.1515/cclm-2023-0590 .
doi: 10.1515/cclm-2023-0590
Daniels, S, Wei, H, van Tongeren, M, Denning, DW. Are platelet volume indices of clinical use in COVID-19? A systematic review. Front Cardiovasc Med 2022;9:1031092. https://doi.org/10.3389/fcvm.2022.1031092 .
doi: 10.3389/fcvm.2022.1031092
Dobrijević, D, Antić, J, Rakić, G, Katanić, J, Andrijević, L, Pastor, K. Clinical hematochemical parameters in differential diagnosis between pediatric SARS-CoV-2 and influenza virus infection: an automated machine learning approach. Children 2023;10:761. https://doi.org/10.3390/children10050761 .
doi: 10.3390/children10050761
Dobrijević, D, Andrijević, L, Antić, J, Rakić, G, Pastor, K. Hemogram-based decision tree models for discriminating COVID-19 from RSV in infants. J Clin Lab Anal 2023;37:e24862. https://doi.org/10.1002/jcla.24862 .
doi: 10.1002/jcla.24862